Suvi Tuula Marjukka Orr

This inventor holds 13 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Immunome, Inc., Pfizer Corporation, Zeno Management, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suvi Tuula Marjukka Orr. Retrieved from https://idiyas.com/inventor/suvi-tuula-marjukka-orr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 5)

% Patents Active = 84.6

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

Zeno Management, Inc.

patent

Years Active: 2016-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545716 - IMMUNOCONJUGATES AND METHODS (2026-02-10),

2. 12378232 - Cyclin dependent kinase inhibitors (2025-08-05),

3. 12285492 - Immunoconjugates and methods (2025-04-29),

4. 12280121 - Immunoconjugates and methods (2025-04-21),

5. 12274754 - Immunoconjugates and methods (2025-04-14),

6. 12268750 - Immunoconjugates and methods (2025-04-08),

7. 12186403 - Immunoconjugates and methods (2025-01-07),

8. 11806405 - Immunoconjugates and methods (2023-11-07),

9. 11220494 - Cyclin dependent kinase inhibitors (2022-01-11),

10. 10766884 - Cyclin dependent kinase inhibitors (2020-09-08),

11. 9758538 - Pyrimidine derivatives (2017-09-12),

12. 9440949 - Diacylglycerol acyltransferase 2 inhibitors (2016-09-13),

13. 9260439 - Dihydropyrrolopyrimidine derivatives (2016-02-16),

Title: Suvi Tuula Marjukka Orr: Innovator in Cancer Treatment

Introduction

Suvi Tuula Marjukka Orr is a prominent inventor based in San Diego, California. She has made significant contributions to the field of cancer treatment through her innovative research and development. With a total of 12 patents to her name, Orr has established herself as a leading figure in the biotechnology sector.

Latest Patents

Among her latest patents are groundbreaking inventions such as cyclin-dependent kinase inhibitors. This invention relates to compounds that play a crucial role in regulating the cell cycle, which is vital for cancer treatment. Additionally, she has developed immunoconjugates that include a linking group for connecting an antibody targeting ligand to a drug. These immunoconjugates are particularly useful for delivering drugs to specific cells or tissues, enhancing the effectiveness of cancer therapies.

Career Highlights

Orr has worked with notable companies in the biotechnology industry, including Pfizer Corporation and Immunome, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in medical research.

Collaborations

Throughout her career, Suvi has collaborated with talented individuals such as Xiaojun Han and Kevin Duane Bunker. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Suvi Tuula Marjukka Orr is a remarkable inventor whose work has the potential to transform cancer treatment. Her dedication to innovation and collaboration continues to drive advancements in the field of biotechnology.

Profile summary based on public USPTO records.